【24h】

New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension.

机译:超声心动图预后因素在肺动脉高压中的死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: The present role of echocardiography is generally restricted to screening for pulmonary arterial hypertension (PAH). The aim of our study was to identify new echocardiographic prognostic factors for mortality in PAH which would give this imaging modality a genuine role in patient management. METHODS AND RESULTS: At inclusion, all patients underwent right cardiac catheterization and echocardiography. Seventy-nine patients were followed for a median of 12 months, of whom 16 died of their pulmonary disease. We identified seven echocardiographic parameters that were associated with mortality, four of which have not previously been described in the literature: mean pulmonary artery pressure (PAP) >or=49 mmHg (P = 0.012), dPAP >or= 29 mmHg (P = 0.006), abnormal end-diastolic septal curve (P = 0.027), and inferior vena cava diameter >or=20 mm with respiratory variation of diameter <50% (P = 0.018). These parameters remained significant after adjustment for NYHA class and 6 min walk test distance. CONCLUSION: Echocardiography should take an important place in the management of PAH and should not be restricted merely to screening for the disease.
机译:目的:超声心动图的当前作用通常仅限于筛查肺动脉高压(PAH)。我们研究的目的是确定PAH死亡率的新的超声心动图预后因素,这将使这种成像方式在患者管理中发挥真正作用。方法与结果:所有患者均接受了右心导管检查和超声心动图检查。对79名患者进行了随访,平均中位时间为12个月,其中16人死于肺部疾病。我们确定了与死亡率相关的七个超声心动图参数,文献中以前没有描述其中四个:平均肺动脉压(PAP)>或= 49 mmHg(P = 0.012),dPAP>或= 29 mmHg(P = 0.006),舒张末期室间隔曲线异常(P = 0.027),下腔静脉直径>或= 20 mm,呼吸变化的直径<50%(P = 0.018)。在调整NYHA等级和6分钟步行测试距离后,这些参数仍然很重要。结论:超声心动图检查在PAH的治疗中应占有重要地位,而不仅限于筛查疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号